Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) therapies for cancer. Led by a world-class management team with significant experience in cell therapy, Allogene is developing a pipeline of "off-the-shelf" CAR T cell therapy candidates with the goal of delivering readily available cell therapy faster, more reliably and at greater scale to more patients.
AlloCAR T cell therapies are engineered from cells of healthy donors, which is intended to allow for creation of inventory for on demand use in patients. This approach is designed to eliminate the need to create personalized therapy from a patient's own cells, simplify manufacturing, and reduce the time patients must wait for CAR T cell treatment. The Allogene portfolio includes rights to 16 pre-clinical CAR T cell therapy targets and UCART19, an AlloCAR T therapy candidate currently in Phase 1 sponsored by Servier for the treatment of relapsed/refractory acute lymphoblastic leukemia (ALL). For more information, please visit www.allogene.com, and follow @AllogeneTx on Twitter and LinkedIn.
Allogene is seeking a Senior Accounting Analyst who will primarily be responsible for Clinical Trial accounting, as well as helping the company address technical accounting issues arising from business transactions or the implementation of new accounting pronouncements. Reporting to the Director, Technical Accounting this Sr. Accounting Analyst is essential to ensuring the accuracy and timeliness of reporting in accordance with GAAP, SEC requirements and best practices. This individual will interact with various levels of management and third parties across financial and operational projects and initiatives. The ideal candidate is a licensed CPA with biotechnology or pharmaceutical experience.
Responsibilities include, but are not limited to:
Execution of critical accounting processes related to clinical trial accounting, collaboration accrual accounting and other areas of accounting related to the clinical trial processes.
Collaborate with multiple stakeholders within the finance and clinical operations organization to manage the clinical trial progress against budget and ensure the recording of clinical accruals on a timely and accurate basis.
Participate in the development and execution of deliverables for internal as well as external audit, legal and other parties to ensure timely completion of the company's quarterly review and annual audit
Assist the technical accounting team in assessing analyzing and concluding on new applicable accounting literature, SEC rules and regulations and significant or unusual transactions as well as roll out related implementation
Assist with the financial statement close process, executing period end procedures over clinical trial accounting, collaboration agreement accounting and other research and development accruals.
Participate in the company's development and roll out of accounting policies and procedures that meet SOX requirements
Other ad hoc projects and roles as appropriate
Position Requirements & Experience:
Bachelor's degree (or higher) in Accounting or Finance with at least 4 years of progressive accounting experience in publicly traded companies
CPA and Big Four experience strongly preferred
Experience with NetSuite ERP system is favored
Proficiency in Excel and Word and ability to learn new systems quickly are required
An independent problem-solver with strong work ethics and intellectual curiosity will thrive
Attention to detail, ability to multi-task, and strong interpersonal skills including verbal and written communication are essential in this collaborative work environment
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
Ability to work independently and as part of a team.
Candidates must be authorized to work in the U.S.
As an equal opportunity employer, Allogene Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact the careers email at www.allogene.com for assistance.
For more information about equal employment opportunity protections, please view the 'EEO is the Law' poster.
Allogene Therapeutics, Inc.